An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer

The authors have previously designed, developed, and characterized a novel microencapsulated formulation as a platform for the targeted delivery of therapeutics in an animal model of type 2 diabetes, using the drug probucol (PB). The aim of this study was to optimize PB microcapsules by incorporatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Watts, Gerald F, Arfuso, Frank, Al-Salami, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189710/
https://www.ncbi.nlm.nih.gov/pubmed/25302020
http://dx.doi.org/10.2147/DDDT.S68247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189710/
https://www.ncbi.nlm.nih.gov/pubmed/25302020
http://dx.doi.org/10.2147/DDDT.S68247

Ejemplares similares